Literature DB >> 33539014

Signal Transduction in Immune Cells and Protein Kinases.

Monica Neagu1,2,3, Carolina Constantin4,5.   

Abstract

Immune response relies upon several intracellular signaling events. Among the protein kinases involved in these pathways, members of the protein kinase C (PKC) family are prominent molecules because they have the capacity to acutely and reversibly modulate effector protein functions, controlling both spatial distribution and dynamic properties of the signals. Different PKC isoforms are involved in distinct signaling pathways, with selective functions in a cell-specific manner.In innate system, Toll-like receptor signaling is the main molecular event triggering effector functions. Various isoforms of PKC can be common to different TLRs, while some of them are specific for a certain type of TLR. Protein kinases involvement in innate immune cells are presented within the chapter emphasizing their coordination in many aspects of immune cell function and, as important players in immune regulation.In adaptive immunity T-cell receptor and B-cell receptor signaling are the main intracellular pathways involved in seminal immune specific cellular events. Activation through TCR and BCR can have common intracellular pathways while others can be specific for the type of receptor involved or for the specific function triggered. Various PKC isoforms involvement in TCR and BCR Intracellular signaling will be presented as positive and negative regulators of the immune response events triggered in adaptive immunity.

Entities:  

Keywords:  Adaptive immune cells; Innate immune cells; Intracellular signaling; Protein kinase

Mesh:

Substances:

Year:  2021        PMID: 33539014     DOI: 10.1007/978-3-030-49844-3_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  111 in total

Review 1.  T cell activation and the cytoskeleton.

Authors:  O Acuto; D Cantrell
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

3.  Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases.

Authors:  Karen Anderson; Michael Fitzgerald; Michelle Dupont; Tao Wang; Nancy Paz; Marion Dorsch; Aileen Healy; Yajun Xu; Tim Ocain; Lisa Schopf; Bruce Jaffee; Dominic Picarella
Journal:  Autoimmunity       Date:  2006-09       Impact factor: 2.815

Review 4.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

5.  Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets.

Authors:  Claudio Agostinelli; Hasan Rizvi; Jennifer Paterson; Vishvesh Shende; Ayse U Akarca; Elena Agostini; Fabio Fuligni; Simona Righi; Sebastiano Spagnolo; Pier Paolo Piccaluga; Edward A Clark; Stefano A Pileri; Teresa Marafioti
Journal:  Am J Surg Pathol       Date:  2014-10       Impact factor: 6.394

6.  Involvement of PKCalpha/beta in TLR4 and TLR2 dependent activation of NF-kappaB.

Authors:  Karim Asehnoune; Derek Strassheim; Sanchayita Mitra; Jae Yeol Kim; Edward Abraham
Journal:  Cell Signal       Date:  2005-03       Impact factor: 4.315

7.  Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells.

Authors:  G Baier; D Telford; L Giampa; K M Coggeshall; G Baier-Bitterlich; N Isakov; A Altman
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

Review 8.  Exploitation of protein kinase C: a useful target for cancer therapy.

Authors:  Ashhar S Ali; Shadan Ali; Bassel F El-Rayes; Philip A Philip; Fazlul H Sarkar
Journal:  Cancer Treat Rev       Date:  2008-09-07       Impact factor: 12.111

Review 9.  Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders.

Authors:  Ezra Aksoy; Michel Goldman; Fabienne Willems
Journal:  Int J Biochem Cell Biol       Date:  2004-02       Impact factor: 5.085

10.  Vascular endothelial growth factor stimulates protein kinase CbetaII expression in chronic lymphocytic leukemia cells.

Authors:  Simon T Abrams; Benjamin R B Brown; Mirko Zuzel; Joseph R Slupsky
Journal:  Blood       Date:  2010-02-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.